PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW064750View Pathway |
signaling
SDMA SignalingHomo sapiens
|
Creator: Ana Marcu Created On: May 31, 2018 at 10:39 Last Updated: May 31, 2018 at 10:39 |
PW146330View Pathway |
drug action
Sea salt Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 17:57 Last Updated: October 07, 2023 at 17:57 |
PW146561View Pathway |
drug action
Secnidazole Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 18:30 Last Updated: October 07, 2023 at 18:30 |
PW176175View Pathway |
Secnidazole Predicted Metabolism Pathway newHomo sapiens
Metabolites of Secnidazole are predicted with biotransformer.
|
Creator: Omolola Created On: November 30, 2023 at 10:10 Last Updated: November 30, 2023 at 10:10 |
PW128413View Pathway |
drug action
Secobarbital Action PathwayHomo sapiens
Secobarbital is a barbiturate derivative that serves as a short-term treatment for insomnia, offering an array of properties including anesthesia induction, anticonvulsant effects, and sedative-hypnotic capabilities. It finds use in inducing anesthesia before other general anesthetic agents and for brief surgical, diagnostic, or therapeutic procedures with limited painful stimuli. While barbiturates like secobarbital don't provide significant analgesia and might even incite excitation in the presence of pain, their metabolization primarily occurs through the hepatic microsomal enzyme system, with resultant metabolites being excreted mainly through urine, and occasionally through feces. Overdose manifestations encompass lethargy, lack of coordination, cognitive impairment, slowed speech, impaired judgment, drowsiness, shallow breathing, instability, and, in severe instances, potential progression to coma and fatality.
|
Creator: Dorsa Yahya Rayat Created On: August 28, 2023 at 12:10 Last Updated: August 28, 2023 at 12:10 |
PW144543View Pathway |
drug action
Secobarbital Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 13:51 Last Updated: October 07, 2023 at 13:51 |
PW176134View Pathway |
Secobarbital Predicted Metabolism Pathway newHomo sapiens
Metabolites of Secobarbital are predicted with biotransformer.
|
Creator: Omolola Created On: November 29, 2023 at 14:13 Last Updated: November 29, 2023 at 14:13 |
PW122258View Pathway |
Secondary metabolites pathwaysBacteria
|
Creator: Ng Ngashangva Created On: October 18, 2018 at 02:03 Last Updated: October 18, 2018 at 02:03 |
PW122259View Pathway |
Secondary metabolites pathways 1539851941Bacteria
|
Creator: WishartLab Created On: October 18, 2018 at 02:39 Last Updated: October 18, 2018 at 02:39 |
PW000977View Pathway |
Secondary Metabolites: Cysteine Biosynthesis from SerineEscherichia coli
The pathway starts with a 3-phosphoglyceric acid interacting with an NAD driven D-3-phosphoglycerate dehydrogenase / α-ketoglutarate reductase resulting in an NADH, a hydrogen ion and a phosphohydroxypyruvic acid. This compound then interacts with an L-glutamic acid through a 3-phosphoserine aminotransferase / phosphohydroxythreonine aminotransferase resulting in a oxoglutaric acid and a DL-D-phosphoserine. The latter compound then interacts with a water molecule through a phosphoserine phosphatase resulting in a phosphate and an L-serine. The L-serine interacts with an acetyl-coa through a serine acetyltransferase resulting in a release of a Coenzyme A and a O-Acetylserine. The O-acetylserine then interacts with a hydrogen sulfide through a O-acetylserine sulfhydrylase A resulting in an acetic acid, a hydrogen ion and an L-cysteine
|
Creator: miguel ramirez Created On: July 15, 2015 at 11:14 Last Updated: July 15, 2015 at 11:14 |